The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies
Open accessAbstract
Resistance to quinolones and fluoroquinolones is being increasingly reported among human but also veterinary isolates during the last two to three decades, very likely as a consequence of the large clinical usage of those antibiotics. Even if the principle mechanisms of resistance to quinolones are chromosome-encoded, due to modifications of molecular targets (DNA gyrase and topoisomerase IV), decreased outer-membrane permeability (porin defect), and overexpression of naturally occurring efflux, the emergence of plasmid-mediated quinolone resistance (PMQR) has been reported since 1998. Although these PMQR determinants confer low-level resistance to quinolones and/or fluoroquinolones, they are a favorable background for selection of additional chromosome-encoded quinolone resistance mechanisms. Different transferable mechanisms have been identified, corresponding to the production of Qnr proteins, of the aminoglycoside acetyltransferase AAC(6')-Ib-cr, or of the QepA-type or OqxAB-type efflux pumps. Qnr proteins protect target enzymes (DNA gyrase and type IV topoisomerase) from quinolone inhibition. The AAC(6')-Ib-cr determinant acetylates several fluoroquinolones, such as norfloxacin and ciprofloxacin. Finally, the QepA and OqxAB efflux pumps extrude fluoroquinolones from the bacterial cell. A series of studies have identified the environment to be a reservoir of PMQR genes, with farm animals and aquatic habitats being significantly involved. In addition, the origin of the qnr genes has been identified, corresponding to the waterborne species Shewanella sp. Altogether, the recent observations suggest that the aquatic environment might constitute the original source of PMQR genes, that would secondly spread among animal or human isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-06 · Cited by 757
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
IS CR Elements: Novel Gene-Capturing Systems of the 21st Century?
Toleman, M. A., Bennett, P. M., & Walsh, T. R. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-05 · Cited by 587
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments
Hopkins, K. L., Davies, R. H., & Threlfall, E. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.02.006 · Cited by 557
Yamane, K., Wachino, J.-I., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00339-07 · Cited by 467
Cavaco, L. M., Hasman, H., Xia, S., & Aarestrup, F. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-08 · Cited by 441
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
qnrB , Another Plasmid-Mediated Gene for Quinolone Resistance
Jacoby, G. A., Walsh, K. E., Mills, D. M., Walker, V. J., Oh, H., Robicsek, A., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1178-1182.2006 · Cited by 400
Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA
Poirel, L., Rodriguez-Martinez, J.-M., Mammeri, H., Liard, A., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3523-3525.2005 · Cited by 394
Self-citationVan Bambeke, F., Michot, J.-M., Van Eldere, J., & Tulkens, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01131.x · Cited by 342
Wang, M., Guo, Q., Xu, X., Wang, X., Ye, X., Wu, S., Hooper, D. C., & Wang, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01400-08 · Cited by 324
Plasmid-mediated quinolone resistance: an update
Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0120-2 · Cited by 306
Quinolone generations: natural history or natural selection?
Ball, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 302
Mechanisms of quinolone action and microbial response
Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 288
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in Shigella flexneri 2b
Hata, M., Suzuki, M., Matsumoto, M., Takahashi, M., Sato, K., Ibe, S., & Sakae, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.801-803.2005 · Cited by 287
oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
Kim, H. B., Wang, M., Park, C. H., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-08 · Cited by 271
Périchon, B., Courvalin, P., & Galimand, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-07 · Cited by 266
Hansen, L. H., Jensen, L. B., Sørensen, H. I., & Sørensen, S. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm167 · Cited by 258
Plasmid‐Mediated Quinolone Resistance in Non‐Typhi Serotypes of Salmonella enterica
Gay, K., Robicsek, A., Strahilevitz, J., Park, C. H., Jacoby, G., Barrett, T. J., Medalla, F., Chiller, T. M., & Hooper, D. C. (2006) · Clinical Infectious Diseases · doi:10.1086/505397 · Cited by 242
Cattoir, V., Poirel, L., Aubert, C., Soussy, C.-J., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070677 · Cited by 229
Self-citationPlasmid-Encoded Multidrug Efflux Pump Conferring Resistance to Olaquindox in Escherichia coli
Hansen, L. H., Johannesen, E., Burmølle, M., Sørensen, A. H., & Sørensen, S. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3332-3337.2004 · Cited by 215
Jacoby, G., Cattoir, V., Hooper, D., Martínez-Martínez, L., Nordmann, P., Pascual, A., Poirel, L., & Wang, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00147-08 · Cited by 202
Self-citationAhmed, A. M., Motoi, Y., Sato, M., Maruyama, A., Watanabe, H., Fukumoto, Y., & Shimamoto, T. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01054-07 · Cited by 200
Vetting, M. W., Hegde, S. S., Fajardo, J. E., Fiser, A., Roderick, S. L., Takiff, H. E., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi052130w · Cited by 190
Veldman, K., Cavaco, L. M., Mevius, D., Battisti, A., Franco, A., Botteldoorn, N., Bruneau, M., Perrin-Guyomard, A., Cerny, T., De Frutos Escobar, C., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr084 · Cited by 181
Fluoroquinolone Antibiotics: Microbiology, Pharmacokinetics and Clinical Use
Paton, J. H., & Reeves, D. S. (1988) · Drugs · doi:10.2165/00003495-198836020-00004 · Cited by 161
Plasmid-Mediated Quinolone Resistance in Gram-Negative Bacterial Species: An Update
Cattoir, V., & Nordmann, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581879 · Cited by 153
Self-citationPLASMID-MEDIATED RESISTANCE TO NALIDIXIC ACID IN SHIGELLA DYSENTERIAE TYPE 1
Munshi, M. H., Haider, K., Rahaman, M. M., Sack, D., Ahmed, Z. U., & Morshed, M. G. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90957-3 · Cited by 153
Zhao, J., Chen, Z., Chen, S., Deng, Y., Liu, Y., Tian, W. X., Huang, X., Wu, C., Sun, Y., Sun, Y., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00139-10 · Cited by 152
Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants
Poirel, L., Liard, A., Rodríguez-Martínez, J. M., & Nordmann, P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki371 · Cited by 146
Self-citationInteraction of plasmid and host quinolone resistance
Martínez-Martínez, L. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg157 · Cited by 118
Liu, J., Deng, Y., Zeng, Z., Gao, J.-H., Chen, L., Arakawa, Y., & Zhang-liu, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-07 · Cited by 112
Vibrio splendidus as the Source of Plasmid-Mediated QnrS-Like Quinolone Resistance Determinants
Cattoir, V., Poirel, L., Mazel, D., Soussy, C., & Nordmann, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00070-07 · Cited by 112
Self-citationNewqnrGene Cassettes Associated with Superintegron Repeats inVibrio choleraeO1
da Fonseca, É. L., Freitas, F. D. S., Vieira, V. V., & Vicente, A. C. P. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.080132 · Cited by 110
Minarini, L. A. D. R., Poirel, L., Cattoir, V., Darini, A. L. D. C., & Nordmann, P. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn237 · Cited by 108
Self-citationCitrobacter spp. as a Source of qnrB Alleles
Jacoby, G. A., Griffin, C. M., & Hooper, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05187-11 · Cited by 107
Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones
Arsene, S., & Leclercq, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-07 · Cited by 98
Fortini, D., Fashae, K., García-Fernández, A., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr085 · Cited by 98
Bönemann, G., Stiens, M., Pühler, A., & Schlüter, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00378-06 · Cited by 95
Escherichia coli of poultry food origin as reservoir of sulphonamide resistance genes and integrons
Soufi, L., Sáenz, Y., Vinué, L., Abbassi, M. S., Ruiz, E., Zarazaga, M., Hassen, A. B., Hammami, S., & Torres, C. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.11.008 · Cited by 93
Quiroga, M. P., Andres, P. O., Petroni, A., Soler‐Bistué, A., Guerriero, L., Vargas, L. J., Zorreguieta, Á., Tokumoto, M., Quiroga, C., Tolmasky, M. E., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00726-07 · Cited by 90
Xia, R., Guo, X., Zhang, Y., & Xu, H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01668-09 · Cited by 86
Poirel, L., Pitout, J. D. D., Calvo, L., Rodríguez-Martínez, J. M., Church, D. L., & Nordmann, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1525-1527.2006 · Cited by 86
Self-citationHansen, L. H., S⊘rensen, S. J., Jørgensen, H. S., & Jensen, L. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.378 · Cited by 85
Takasu, H., Suzuki, S., Reungsang, A., & Viet, P. H. (2011) · Microbes and Environments · doi:10.1264/jsme2.me10204 · Cited by 81
Rodríguez-Martínez, J. M., Velasco, C., Garcı́a, I., Cano, M. E., Martı́nez-Martı́nez, L., & Pascual, Á. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-06 · Cited by 75
IS Ecp1 -Mediated Transposition of qnrB -Like Gene in Escherichia coli
Cattoir, V., Nordmann, P., Silva-Sánchez, J., Espinal, P., & Poirel, L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-08 · Cited by 69
Self-citationQnr-like pentapeptide repeat proteins in Gram-positive bacteria
Rodríguez-Martínez, J. M., Velasco, C., Briales, A., García, I., Conejo, M. C., & Pascual, Á. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn115 · Cited by 67
Poirel, L., Cattoir, V., Soares, A., Soussy, C., & Nordmann, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01082-06 · Cited by 54
Self-citationCoexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae
Hu, F., Xu, X., Zhu, D., & Wang, M. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00757.x · Cited by 41
Plasmid-Mediated QnrS2 Determinant from a Clinical Aeromonas veronii Isolate
Sánchez‐Céspedes, J., Blasco, M. D., Martí, S., Alba, V., Alcalde, E., Esteve, C., & Vilà, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00287-08 · Cited by 41
Novel Variant of the qnrB Gene, qnrB12 , in Citrobacter werkmanii
Kehrenberg, C., Friederichs, S., de Jong, A., & Schwarz, Š. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01042-07 · Cited by 35
Gibson, J. S., Cobbold, R. N., Heisig, P., Sidjabat, H. E., Kyaw-Tanner, M. T., & Trott, D. J. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.11.031 · Cited by 32
Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae
Fu-pin, Hu, Xiaogang, et al. (2008) · 中国药理学报:英文版 · Cited by 29
Jeong, J., Kim, E. S., Choi, S., Kwon, H., Lee, S.-R., Lee, S., Kim, M., Woo, J. H., & Kim, Y. S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.07.015 · Cited by 23
Cited by
Cabello, F. C., Godfrey, H. P., Tomova, A., Ivanova, L., Dölz, H., Millanao, A., & Buschmann, A. H. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12134 · Cited by 898
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
The Scourge of Antibiotic Resistance: The Important Role of the Environment
Finley, R. L., Collignon, P., Larsson, D. G. J., McEwen, S. A., Li, X.-Z., Gaze, W. H., Reid-Smith, R., Timinouni, M., Graham, D. W., & Topp, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit355 · Cited by 636
Cabello, F. C., Godfrey, H. P., Buschmann, A. H., & Dölz, H. J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00100-6 · Cited by 507
Plasmids, a molecular cornerstone of antimicrobial resistance in the One Health era
Castañeda-Barba, S., Top, E. M., & Stalder, T. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00926-x · Cited by 379
Metadata
- Authors
- Poirel, L., Cattoir, V., & Nordmann, P.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 24-24
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2132942065
- Cited by
- 276
- References
- 61
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.